In Brief: PharmaPrint
This article was originally published in The Tan Sheet
Executive Summary
PharmaPrint: Michael Tempesta, PhD, to senior VP-research, the Irvine, Calif.-based herbal medicine developer and marketer announces. Tempesta previously served as president of NatProd Consulting services and as chief scientific officer for both Larex, Inc. and San Francisco-based Shaman Pharmaceuticals. PharmaPrint also promotes President and CEO Elliot Friedman to chairman; Exec VP and Chief Operating Officer Robert Burgess is named president...